PUBLISHER: TechSci Research | PRODUCT CODE: 1719233
PUBLISHER: TechSci Research | PRODUCT CODE: 1719233
Neomycin Sulphate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Neomycin Sulphate Market was valued at USD 246.80 million in 2024 and is projected to reach USD 382.05 million by 2030, growing at a CAGR of 5.22%. Neomycin sulphate, a broad-spectrum aminoglycoside antibiotic, is widely used to treat bacterial infections in both humans and animals. Its effectiveness, affordability, and application in topical and oral formulations make it a preferred choice in managing infections such as skin conditions and gastrointestinal disorders. The market is expanding due to rising incidences of bacterial infections and increased focus on preventive healthcare, especially in developing regions where limited access to clean water and sanitation persists. Neomycin sulphate's therapeutic versatility, combined with its cost-effectiveness, continues to support its use across both pharmaceutical and veterinary domains.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 246.80 Million |
| Market Size 2030 | USD 382.05 Million |
| CAGR 2025-2030 | 5.22% |
| Fastest Growing Segment | Direct |
| Largest Market | Asia Pacific |
Key Market Drivers
Growth in Healthcare Industry
The ongoing expansion of the global healthcare industry is significantly driving demand for neomycin sulphate. With global healthcare generating over USD 4 trillion annually, the pharmaceutical and biotechnology segments alone account for approximately USD 850 billion. Neomycin sulphate plays a critical role in treating infections of the skin, eyes, and intestines, and is frequently used in both over-the-counter and prescription drugs. The growing burden of infectious diseases, especially in developing economies with inadequate sanitation infrastructure, reinforces the need for effective antimicrobials. Healthcare institutions rely heavily on neomycin sulphate for its broad-spectrum antibacterial capabilities, particularly in outpatient and surgical environments. As healthcare access improves globally, so does the reliance on reliable antibiotics like neomycin sulphate to manage and prevent infection-related complications.
Key Market Challenges
Adverse Side Effects
A major challenge in the global neomycin sulphate market is the potential for severe side effects associated with its prolonged or high-dose use. While effective, the antibiotic can cause nephrotoxicity and ototoxicity, leading to kidney damage and hearing loss. These risks have led to increased caution among healthcare providers and stricter regulatory oversight. As a result, neomycin sulphate usage is often limited to short-term or topical applications in human medicine. Meanwhile, the veterinary sector faces heightened scrutiny due to the risk of antibiotic residues in animal-derived products, which raises public health concerns. This has led to a gradual shift toward alternative antibiotics with better safety profiles.
Key Market Trends
Rising Demand of Neomycin Sulphate in Veterinary Sectors
A growing trend in the neomycin sulphate market is its increasing use in veterinary medicine. Chickens dominate global poultry production, comprising over 90% of the sector, followed by ducks, turkeys, guineafowl, and geese. As global demand for animal protein rises, so does the need for effective veterinary antibiotics. Neomycin sulphate is widely used to treat gastrointestinal and topical bacterial infections in livestock and poultry due to its proven efficacy against gram-negative bacteria. This trend is particularly pronounced in regions with large-scale animal farming operations, where maintaining animal health is essential for productivity and food safety.
Key Market Players
- Pfizer Limited
- Shandong Qilu King-Phar Pharmaceutical Co., Ltd.
- Myland Pharma Pvt Ltd
- Xi'an International Healthcare Factory Co., Ltd.
- Shandong Yifan Chemical Technology Co., Ltd.
- Xi'an Henrikang Biotech Co., Ltd.
- Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.
- Jinyao Xinrui Pharmaceutical
- Xinyu Pharmaceutical
- Renfu Pharmaceutical
Report Scope:
In this report, the Global Neomycin Sulphate Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Neomycin Sulphate Market, By Sales Channel:
- Direct
- Indirect
Neomycin Sulphate Market, By End Use:
- Skin Infection
- Eye Infection
- Ear Infection
- Vaccine Production
- Veterinary Medicine
- Others
Neomycin Sulphate Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Neomycin Sulphate Market.
Available Customizations:
Global Neomycin Sulphate Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Neomycin Sulphate Market
5. Global Neomycin Sulphate Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Sales Channel (Direct, Indirect)
- 5.2.2. By End Use (Skin Infection, Eye Infection, Ear Infection, Vaccine Production, Veterinary Medicine, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
- 5.3. Market Map
6. North America Neomycin Sulphate Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Sales Channel
- 6.2.2. By End Use
- 6.2.3. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Neomycin Sulphate Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Sales Channel
- 6.3.1.2.2. By End Use
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Mexico Neomycin Sulphate Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Sales Channel
- 6.3.2.2.2. By End Use
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Canada Neomycin Sulphate Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Sales Channel
- 6.3.3.2.2. By End Use
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Neomycin Sulphate Market Outlook
7. Europe Neomycin Sulphate Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Sales Channel
- 7.2.2. By End Use
- 7.2.3. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Neomycin Sulphate Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Sales Channel
- 7.3.1.2.2. By End Use
- 7.3.1.1. Market Size & Forecast
- 7.3.2. Germany Neomycin Sulphate Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Sales Channel
- 7.3.2.2.2. By End Use
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Neomycin Sulphate Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Sales Channel
- 7.3.3.2.2. By End Use
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Neomycin Sulphate Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Sales Channel
- 7.3.4.2.2. By End Use
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Neomycin Sulphate Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Sales Channel
- 7.3.5.2.2. By End Use
- 7.3.5.1. Market Size & Forecast
- 7.3.1. France Neomycin Sulphate Market Outlook
8. Asia Pacific Neomycin Sulphate Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Sales Channel
- 8.2.2. By End Use
- 8.2.3. By Country
- 8.3. Asia Pacific: Country Analysis
- 8.3.1. China Neomycin Sulphate Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Sales Channel
- 8.3.1.2.2. By End Use
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Neomycin Sulphate Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Sales Channel
- 8.3.2.2.2. By End Use
- 8.3.2.1. Market Size & Forecast
- 8.3.3. South Korea Neomycin Sulphate Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Sales Channel
- 8.3.3.2.2. By End Use
- 8.3.3.1. Market Size & Forecast
- 8.3.4. Japan Neomycin Sulphate Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Sales Channel
- 8.3.4.2.2. By End Use
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Neomycin Sulphate Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Sales Channel
- 8.3.5.2.2. By End Use
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Neomycin Sulphate Market Outlook
9. South America Neomycin Sulphate Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Sales Channel
- 9.2.2. By End Use
- 9.2.3. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Neomycin Sulphate Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Sales Channel
- 9.3.1.2.2. By End Use
- 9.3.1.1. Market Size & Forecast
- 9.3.2. Argentina Neomycin Sulphate Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Sales Channel
- 9.3.2.2.2. By End Use
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Colombia Neomycin Sulphate Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Sales Channel
- 9.3.3.2.2. By End Use
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Brazil Neomycin Sulphate Market Outlook
10. Middle East and Africa Neomycin Sulphate Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Sales Channel
- 10.2.2. By End Use
- 10.2.3. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Neomycin Sulphate Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Sales Channel
- 10.3.1.2.2. By End Use
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Saudi Arabia Neomycin Sulphate Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Sales Channel
- 10.3.2.2.2. By End Use
- 10.3.2.1. Market Size & Forecast
- 10.3.3. UAE Neomycin Sulphate Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Sales Channel
- 10.3.3.2.2. By End Use
- 10.3.3.1. Market Size & Forecast
- 10.3.1. South Africa Neomycin Sulphate Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Global Neomycin Sulphate Market: SWOT Analysis
14. Porters Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Pfizer Limited
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
- 15.2. Shandong Qilu King-Phar Pharmaceutical Co., Ltd.
- 15.3. Myland Pharma Pvt Ltd
- 15.4. Xi'an International Healthcare Factory Co., Ltd.
- 15.5. Shandong Yifan Chemical Technology Co., Ltd.
- 15.6. Xi'an Henrikang Biotech Co., Ltd.
- 15.7. Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.
- 15.8. Jinyao Xinrui Pharmaceutical
- 15.9. Xinyu Pharmaceutical
- 15.10. Renfu Pharmaceutical
16. Strategic Recommendations
17. About Us & Disclaimer
